On Monday, October 5, the Nobel Assembly at Sweden's Karolinska Institute awarded the 2026 Nobel Prize in Physiology or Medicine to Karl Deisseroth (Stanford University), Peter Hegemann (Humboldt University of Berlin) and Georg Nagel (University of Würzburg) for their discoveries on light-activated ion channels and optogenetics, as reported by Argentina's La Nación and Colombia's El Tiempo. The prize is worth 12 million Swedish kronor and will be presented on December 10 in Stockholm.
The news will be read as a triumph of cutting-edge science. It is that. But the interesting part lies elsewhere: in the humble origin of the tool, and in what it teaches about control. Neither lesson is comfortable.
What won, minus the hype
Hegemann and Nagel studied a light-sensitive protein, channelrhodopsin, found in a single-celled alga of the genus Chlamydomonas. Deisseroth inserted the gene for that protein into rat neurons and managed to switch them on with blue light. He published that work in 2005, and by around 2007 he had shown it worked in the brains of living mice. The result is a technique that can turn specific nerve cells on or off with a pulse of light.
The committee said these findings laid the foundation for a new era in neuroscience. Today, thousands of research groups use optogenetics to study sleep, appetite, decision-making, memory and conditions such as epilepsy, Parkinson's and depression.
Lesson one: the key was in a pond
Nobody designed optogenetics from scratch. Scientists took a mechanism that a microscopic organism had already perfected to orient itself toward light, and moved it into a new context. The innovation wasn't building a new part. It was recognizing the value of one that already existed and that almost nobody was looking at.
That contradicts the favorite story of the average ambitious person: that getting ahead requires resources they don't have yet, whether it's capital, a connection or a break that never comes. Most people don't lack tools. They lack an inventory. They don't know what they have, so they don't know what they can build. Even a cheap phone is enough to start: the starting point is rarely the obstacle. The failure to examine it is.
Studying an alga promised no prizes and no patents. It promised understanding. If you only invest in what pays off tomorrow, you'll never have in hand the piece that decides the day after. At a different scale, an investment built on a five-year horizon follows the same rule: the long term isn't passive patience. It's putting pieces in place before their value is obvious.
Lesson two: control demands precision
Before techniques like this, intervening in the brain largely meant acting on entire regions. Electrodes, drugs or lesions hit many cells at once. You moved everything and watched what changed. Optogenetics offers something else: identifying which specific circuit drives a specific behavior, and acting on that circuit alone.
Bring that into everyday life. When something isn't working (money, a relationship, discipline), the usual reaction is a massive, unfocused intervention: change everything, get motivated, start on Monday, read another list of habits. It's the equivalent of flooding the brain with a chemical and hoping for the best. It rarely works, because nobody has found the switch.
The useful question isn't "How do I change my life?" It's "Which specific decision, at which specific moment, produces the result I don't want?" Until you can answer that, all your effort is well-meaning noise. That's the difference between someone who tests with a method and someone who just keeps pushing, and it's why blowing up isn't the same as failing: an error is only informative when you know exactly what you were testing.
The uncomfortable question: who's flipping your switches?
There's a third reading, and it's the least pleasant. If a behavior can hinge on circuits this specific, the idea that every decision comes from calm, free deliberation loses ground. That doesn't mean you aren't responsible for what you do. It means that if you don't know your own mechanisms, someone else will learn them for you.
Nobody is going to aim a laser at your brain. They don't need to. Platforms learn which stimulus stops your scroll, which notification brings you back and when you're most likely to buy. It works the same way from the date that tells you when to love to the illusion of choosing your own algorithm: effective manipulation doesn't force anything. It just triggers the right circuit at the right moment.
The answer isn't paranoia or a victim narrative. It's mapping yourself as coldly as a lab maps a circuit: what sets you off, when, and with what consequences. The point is to know who's deciding when you say "I decided," and to train the pause between the impulse and the signature.
What to keep
- Inventory before ambition: the decisive tool may be sitting in what you dismiss as too small or irrelevant.
- Precision before intensity: changing everything at once is the most expensive way to learn nothing.
- A map before a reaction: if you don't know your switches, someone else will use them to their advantage.
The PRAXMA mindset
The idea: Real progress doesn't come from new resources or massive effort. It comes from recognizing what already exists and acting precisely on the exact mechanism.
— PRAXMA, Logic over emotion
The fact: The 2026 Nobel Prize in Medicine went to Deisseroth, Hegemann and Nagel for optogenetics, a technique that switches on specific neurons with light thanks to a protein borrowed from a single-celled alga (La Nación, El Tiempo).
PRAXMA's line: "If you don't know your switches, you don't run yourself. You wait for someone else to flip the light."
For anyone who wants to go further, we dig deep into how to take back command of the decisions you call yours Spanish only. We also talk it through on the podcast.
Comentarios (0)
Sé el primero en comentar.
Inicia sesión o crea una cuenta para comentar.
Entrar o crear cuenta